Insider Trading: Celgene Corp (CELG.O)

CELG.O on Nasdaq

86.66USD
22 Jul 2014
Price Change (% chg)

$1.35 (+1.58%)
Prev Close
$85.31
Open
$86.18
Day's High
$87.12
Day's Low
$85.87
Volume
3,518,508
Avg. Vol
5,136,463
52-wk High
$90.50
52-wk Low
$65.76

Search Stocks
ALLES MARK J
Trading Date Type Shares Traded Price Shares Held
30 Jul 2013 Buy 2,577 $52.34 17,560
30 Jul 2013 Buy 3,438 $39.01 17,560
30 Jul 2013 Buy 1,393 $58.04 17,560
30 Jul 2013 Buy 558 $54.85 17,560
30 Jul 2013 Buy 2,392 $62.42 17,560
30 Jul 2013 Buy 2,081 $72.93 17,560
12 Apr 2013 Sell 1,791 $123.00 7,560
12 Apr 2013 Buy 4,583 $0.00 7,560

Institutional Holders

% Shares Owned: 81.95%
# of Holders: 1,272
Total Shares Held: 653,951,206
3 Mo. Net Change: -657,230
# New Positions: 24
# Closed Positions: 15
# Increased Positions: 88
# Reduced Positions: 111
# Net Buyers: -23

Officers & Directors

Name Age Since Current Position

Robert Hugin

59 2011 Chairman of the Board, President, Chief Executive Officer

Mark Alles

55 2014 President, Chief Operating Officer

Jacqualyn Fouse

52 2014 President - Hematology & Oncology

Scott Smith

2014 President - Inflammation & Immunology

Perry Karsen

59 2012 Chief Operations Officer, Executive Vice President

Lawrence Stein

64 2012 Executive Vice President, General Counsel, Corporate Secretary

Thomas Daniel

60 2012 Executive Vice President, President - Research and Early Development

Peter Kellogg

58 2014 Executive Vice President

Michael Casey

68 2007 Lead Independent Director

Richard Barker

65 2012 Independent Director

Carrie Cox

56 2009 Independent Director

Michael Friedman

70 2011 Independent Director

Gilla Kaplan

67 1998 Independent Director

James Loughlin

71 2007 Independent Director

Ernest Mario

76 2007 Independent Director
Search Stocks